ArticleFrontiers in medicine2026
Association of hemodialysis vascular access type with dialysis adequacy and access-related outcomes in patients receiving maintenance hemodialysis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vascular access type may be associated with the delivered hemodialysis dose and access-related morbidity; however, nonrandom access selection introduces confounding. We evaluated the associations of arteriovenous fistula (AVF), arteriovenous graft (AVG), and tunneled central venous catheter (CVC) use with dialysis adequacy and access-related outcomes. Methods: This retrospective study included 285 adults whose index access was first successfully used between 2020 and 2023, with follow-up through 2024. Monthly single-pool Kt/V (spKt/V) measurements during the first 6 months were analyzed using mixed-effects models. Recurrent complications were reported as rates per 100 access-years. Cox regression and Kaplan-Meier methods were used to evaluate the first composite complication and permanent access failure, respectively. Models were adjusted for prespecified baseline factors, including a history of urgent-start dialysis, previous access attempts, vascular mapping, and residual kidney urea clearance; the interval from access creation or placement to first successful use was examined in sensitivity analyses. Results: The AVF, AVG, and CVC groups included 156, 67, and 62 patients, respectively, and contributed 1,632 adequacy measurements. Compared with CVC use, adjusted monthly spKt/V was higher with AVF use ( Conclusions: AVF use was associated with higher dialysis adequacy and a lower burden of access-related complications than CVC use. Among accesses that had reached successful clinical use, AVFs showed longer observed access survival than AVGs and CVCs. Access selection should integrate clinical urgency, vascular anatomy, anticipated access use, comorbidity, residual kidney function, and patient priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.